Why RNA technology leads the immunity race against COVID-19
The quest to build immunity against the ravaging COVID-19 has been led by six vaccine developers including Johnson & Johnson,...
- Thursday, June 11, 2026
BusinessDay
The quest to build immunity against the ravaging COVID-19 has been led by six vaccine developers including Johnson & Johnson,...
Nigeria’s economic capital, Lagos has been the epicentre of COVID-19 spread accounting for 34 percent of the country’s total caseload...
Opportunities for African countries to access COVID-19 has gained more boost as China prepares to supply its coronavirus vaccines to...
The high cost of doing business in Nigeria has often proven to be one of the biggest disincentives for investors....
The biggest research on Lassa fever prevalence in West Africa, run on $26 million funding, has been inaugurated with a...
The new COVID-19 variant, B.1.1.7 is increasingly sending younger adults to hospitals wards as infection spikes in the UK, Tunde...
A new variant of COVID-19 has been parading through the town, pushing researchers to unravel the features that define it....
A new distinct variant of COVID-19, lineage B.1.1.7, which has cancelled Christmas in the UK, has been found in Nigeria,...
The US Food and Drug Administration (FDA) has recommended monitoring a possible outcome of facial paralysis, Bell’s palsy, after distribution...
The importation rate of the COVID-19 pandemic by inbound travellers has increased by 62 percent as Nigeria’s caseload hit 1,145...